Pages that link to "Q56866713"
Jump to navigation
Jump to search
The following pages link to Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients (Q56866713):
Displaying 50 items.
- A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus (Q28138367) (← links)
- Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease (Q28204430) (← links)
- Evidence for the presence of both peroxisome proliferator-activated receptors alpha and beta in the rat spinal cord (Q28566603) (← links)
- PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. (Q30241952) (← links)
- PPARgamma agonists inhibit TGF-beta-PKA signaling in glomerulosclerosis (Q33520918) (← links)
- Peroxisome proliferator-activated receptors: insight into multiple cellular functions (Q33867997) (← links)
- Regulation of lipid and lipoprotein metabolism by PPAR activators (Q33896369) (← links)
- Prostaglandins and fatty acids regulate transcriptional signaling via the peroxisome proliferator activated receptor nuclear receptors (Q33998280) (← links)
- COX-2 and the cyclopentenone prostaglandins - a new chapter in the book of inflammation? (Q33998294) (← links)
- Peroxisome proliferator-activated receptor gamma (PPARgamma) activation and its consequences in humans (Q34232307) (← links)
- Peroxisome proliferator-activated receptor (PPAR) gamma agonists for diabetes (Q34236636) (← links)
- The significance of genetic polymorphisms in modulating the response to lipid-lowering drugs (Q34258208) (← links)
- Novel insulin sensitizers: pharmacogenomic aspects (Q34609164) (← links)
- Peroxisome proliferator activated receptors and obesity (Q34635500) (← links)
- Adipogenesis and fat-cell function in obesity and diabetes (Q34838292) (← links)
- Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets (Q35023612) (← links)
- Energy metabolism and cytotoxicity (Q35299664) (← links)
- Human immunodeficiency virus infection and the liver (Q35875848) (← links)
- How frequent is altered gene expression among susceptibility genes to human complex disorders? (Q36043405) (← links)
- Peroxisome proliferator-activated receptors in lung cancer. (Q36417658) (← links)
- The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects (Q36445381) (← links)
- The Functions of PPARs in Aging and Longevity (Q36478394) (← links)
- X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment (Q36648327) (← links)
- Do PPARgamma Ligands Suppress the Growth of Cholangiocarcinoma or the Cholangiohepatitis Induced by the Tumor? (Q36743971) (← links)
- Current concepts in the pathogenesis of nonalcoholic fatty liver disease (Q36777932) (← links)
- Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer (Q36795404) (← links)
- PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? (Q36889164) (← links)
- Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related Inflammation (Q37114625) (← links)
- Association between APOE, SCARB1, PPARα polymorphisms and serum lipids in a population of Lithuanian adults (Q37114815) (← links)
- PPAR-alpha Ligands as Potential Therapeutic Agents for Wet Age-Related Macular Degeneration (Q37134028) (← links)
- PPAR Ligands for Cancer Chemoprevention (Q37165190) (← links)
- Are the health benefits of fish oils limited by products of oxidation? (Q37350002) (← links)
- Peroxisome proliferator-activated receptors in diabetic nephropathy (Q37412297) (← links)
- PPAR and liver injury in HIV-infected patients (Q37458203) (← links)
- HDL inflammation and atherosclerosis: current and future perspectives (Q37608502) (← links)
- Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities (Q37802379) (← links)
- Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones (Q38297979) (← links)
- Expression of porcine adipocyte transcripts: tissue distribution and differentiation in vitro and in vivo. (Q38320770) (← links)
- PPARs in Alzheimer's Disease (Q40288794) (← links)
- Regulation of PPAR-gamma gene in human promyelocytic HL-60 cell line (Q40640521) (← links)
- Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists (Q40701174) (← links)
- Peroxisome Proliferator-Activated Receptor-gamma Is a Potent Target for Prevention and Treatment in Human Prostate and Testicular Cancer (Q41942327) (← links)
- Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells (Q42526122) (← links)
- Control of pyruvate dehydrogenase kinase gene expression (Q43625199) (← links)
- RU486 antagonizes the inhibitory effect of peroxisome proliferator-activated receptor alpha on interleukin-6 production in vascular endothelial cells (Q44076948) (← links)
- Peroxisome proliferator-activated receptor alpha induces rat sterol carrier protein x promoter activity through two peroxisome proliferator-response elements (Q44532310) (← links)
- Evaluation of childhood exposure to di(2-ethylhexyl) phthalate from perfusion kits during long-term parenteral nutrition. (Q44555152) (← links)
- Modulating effects of chlorogenic acid on lipids and glucose metabolism and expression of hepatic peroxisome proliferator-activated receptor-alpha in golden hamsters fed on high fat diet. (Q45925160) (← links)
- Changes in gene expression profile in human subcutaneous adipose tissue during significant weight loss (Q47297645) (← links)
- PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes (Q47726365) (← links)